Former President Joe Biden Diagnosed with Prostate Cancer, Begins Treatment

 In a sobering health update, former U.S. President Joe Biden, 82, was diagnosed with prostate cancer on May 15, 2025, following a routine medical examination. The announcement, made by his medical team at Walter Reed National Military Medical Center, has drawn widespread attention, prompting discussions about the health challenges facing aging political figures and the importance of early cancer detection.

Biden, who concluded his presidency in January 2025, underwent a comprehensive physical as part of his post-White House care. Doctors detected an elevated prostate-specific antigen (PSA) level, leading to a biopsy that confirmed a localized, low-grade prostate cancer. The malignancy, classified as Gleason Score 6, is considered slow-growing and highly treatable, with a five-year survival rate exceeding 98%.

Biden’s physicians opted for active surveillance initially but recommended a course of radiation therapy to prevent progression, citing his otherwise robust health. Treatment began on May 17 at a specialized oncology center in Delaware, where Biden resides. The regimen, expected to last six weeks, involves targeted external beam radiation, with minimal side effects anticipated.

The diagnosis comes amid Biden’s active post-presidential life, including his work on global democracy initiatives and climate advocacy through his foundation. His medical team emphasized that the cancer was detected early due to regular screenings, a practice Biden has championed since his vice presidency, when he promoted men’s health awareness. The former president, in a brief statement, expressed optimism, urging men over 50 to prioritize PSA tests and thanking supporters for their well-wishes. He also referenced his late son, Beau, who died of brain cancer in 2015, noting that advances in oncology give him hope for others facing similar diagnoses.

Prostate cancer is the second most common cancer among American men, with over 290,000 cases diagnosed annually. Biden’s case has spotlighted the disease’s prevalence, particularly among older men, as one in eight will face it in their lifetime. Medical experts praised the transparency of the announcement, noting it could encourage early detection, especially in underserved communities where screening rates are lower. Biden’s treatment plan allows him to maintain most public engagements, though his team canceled a planned trip to Europe in June to accommodate his schedule.

The news has also fueled speculation about Biden’s political future, though associates dismissed rumors of a 2028 candidacy, citing his age and focus on legacy projects. His diagnosis follows a history of health challenges, including a 1988 brain aneurysm surgery and atrial fibrillation managed with medication. As Biden navigates this new chapter, his resilience and openness have resonated with many, reinforcing his image as a leader confronting personal trials with candor and determination.